INHIBRX BIOSCIENCES INC (INBX) Institutional Ownership and Insiders Activity
INHIBRX BIOSCIENCES INC (INBX) is widely held by institutional investors, with 156 firms reporting positions valued at approximately $1.27B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Morgan Stanley is the largest disclosed holder, reporting approximately $123.94M in INBX holdings in its latest filing.
Recent insider activity includes 14 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
156
Total Reported Value
$1.27B
Largest Holder
Morgan Stanley
Largest Position
$123.94M
Insider Transactions (90d)
14
Latest Filing Quarter
Q2 2026
New Institutional Positions
50
Funds Exiting Positions
29
Top Institutional Owners
View allInvestorReported Balance
- Morgan Stanley$123.94M
- Perceptive Advisors Llc$122.96M
- Sanofi$109.71M
- Viking Global Investors$106.49M
- Bank Of America Corp$79.70M
INBX News
All news- Pfm Health Sciences Q2 2026 Portfolio Activity: Strategic Shifts in Healthcare Stocks
Aug 20, 2026 · valut.ai
- Sanofi Portfolio Analysis: Top Healthcare Holdings as of June 30, 2026
Jul 31, 2026 · valut.ai
Related INBX Institutional Insights:
- INBX 13F Institutional Holders
- INBX Top Institutional Shareholders
- INBX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- INBX Insider Trading & SEC Form 4 Activity
- INBX Articles
- Top Institutional Investor Stock Rankings